Related Experiment Video
Updated: Aug 19, 2026
A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion
Published on: July 17, 2012
MnSOD in mouse heart: acute responses to ischemic preconditioning and ischemia-reperfusion injury
Zhu-Qiu Jin1, Hui-Zhong Zhou, Gary Cecchini
1Cardiology Section (111C 4150 Clement St., San Francisco, CA 94121, USA. Joel.Karliner@med.va.gov
Abstract:
Manganese superoxide dismutase (MnSOD) is one of the main antioxidant enzymes that protects the heart against ischemia-reperfusion (I/R) injury. Ischemic preconditioning (IPC) is a short period of ischemia-reperfusion that reduces subsequent prolonged I/R injury. Although MnSOD localizes in mitochondria, the immediate subcellular distribution of MnSOD in heart after IPC and I/R has not been studied. In a Langendorff mouse heart model, IPC significantly improved cardiac function and reduced the infarction size induced by I/R. Immunoblotting and double immunostaining in fresh preparations revealed that I/R resulted in an increase in cytosolic MnSOD content accompanied by the release of cytochrome c. In contrast, IPC increased mitochondrial MnSOD and reduced cytosolic MnSOD and cytochrome c release induced by I/R. We found that compared with freshly prepared fractions, the freeze-thaw approach results in mitochondrial integrity disruption and release of large amounts of MnSOD into the cytosol along with mitochondrial markers even in the absence of I/R. In contrast, fresh preparations exhibit early MnSOD release into the cytosol after I/R that is prevented by IPC and cyclosporin A administration.
Insights
Ischemia-reperfusion (I/R) injury causes heart damage by releasing manganese superoxide dismutase (MnSOD) into the cytosol. Ischemic preconditioning (IPC) prevents this, preserving cardiac function and reducing injury.
Area of Science:
- Cardiovascular Biology
- Mitochondrial Medicine
- Antioxidant Research
Background:
- Manganese superoxide dismutase (MnSOD) is a key mitochondrial antioxidant enzyme.
- Heart ischemia-reperfusion (I/R) injury is a significant clinical challenge.
- Ischemic preconditioning (IPC) is a protective phenomenon against I/R injury.
Purpose of the Study:
- To investigate the subcellular distribution of MnSOD in the heart during I/R.
- To determine the effect of IPC on MnSOD localization and mitochondrial integrity.
- To elucidate the role of MnSOD release in cardiac I/R injury.
Main Methods:
- Langendorff mouse heart model for simulating I/R injury.
- Immunoblotting and double immunostaining techniques for protein analysis.
- Assessment of cardiac function and infarct size.
Main Results:
- I/R induced MnSOD translocation from mitochondria to the cytosol, correlating with cytochrome c release.
- IPC preserved mitochondrial MnSOD content and reduced cytosolic MnSOD and cytochrome c release.
- Freeze-thaw artifactually disrupted mitochondrial integrity, unlike fresh preparations showing I/R-induced MnSOD release.
Conclusions:
- Cytosolic translocation of MnSOD is an early event in I/R injury.
- IPC protects the heart by maintaining mitochondrial MnSOD localization.
- Fresh preparations are crucial for accurately studying I/R-induced subcellular changes.
